Unique ID issued by UMIN | UMIN000043000 |
---|---|
Receipt number | R000048526 |
Scientific Title | A study on dynamics of anti-influenza drug low susceptibility virus in household transmission |
Date of disclosure of the study information | 2021/01/14 |
Last modified on | 2022/07/18 16:56:39 |
A prospective,observational study on influenza virus infection part2:A study on dynamics of anti-influenza drug low susceptibility virus in household transmission
A study on dynamics of anti-influenza drug low susceptibility virus in household transmission
A study on dynamics of anti-influenza drug low susceptibility virus in household transmission
A study on dynamics of anti-influenza drug low susceptibility virus in household transmission
Japan |
Type A influenza virus infection
Medicine in general | Pneumology | Infectious disease |
Pediatrics | Adult | Child |
Others
NO
To investigate viral dynamics of amino acid substituted virus on target protein after treatment of baloxavir marboxil or oseltamivir phosphate
Others
major secondary objectives:
To investigate viral dynamics of variants after transmission
Exploratory
Explanatory
Not applicable
RNA ratio of variants (PA/I38X, NA/H275Y) compared to wild type in index and secondary patients when transmission occue in addition to whole virus titer
RNA ratio of variants (PA/I38X, NA/H275Y) compared to wild type in index and secondary patients when transmission occue in addition to whole virus titer
Observational
Not applicable |
Not applicable |
Male and Female
For index and 2ndary infected patients,
patients infected influenza A judged by RIDT
patients obtain a written informed consent
For index patients
index patients who incured 2ndary infection in their household members
For 2ndary infected patients
2ndary infected patietns judged by influenza type/atype during 24hr - 7days after onset of infection of index patient
housemmate with index patient
Patients had been treated with anti-influenza drug within 2weeks prior to 1st visit for current infection
Patients with SARS-CoV(+) or had been diagnosed COVID-19 for current infection
860
1st name | Nobuo |
Middle name | |
Last name | Hirotsu |
Hirotsu medical clinic
internal medicine, pediatrics
2130011
Hisamoto 3-6-1-212, Takatsu-ku, Kawasaki
+81-44-822-1933
non@hirotsu.ptu.jp
1st name | Yutaka |
Middle name | |
Last name | Saisho |
Shionogi&Co.,Ltd.
Medical affairs
541-0045
1-8 Doshomachi, 3-Chome, Chuo-ku, Osaka
+81-80-6140-9391
yutaka.saisho@shionogi.co.jp
Hirotsu medical clinic
Shionogi&Co.,Ltd.
Profit organization
still under
still under
+81-3-5543-0196
shuji.nakamura@smo-msr.co.jp
NO
2021 | Year | 01 | Month | 14 | Day |
Unpublished
Open public recruiting
2020 | Year | 10 | Month | 30 | Day |
2020 | Year | 11 | Month | 10 | Day |
2021 | Year | 01 | Month | 14 | Day |
2022 | Year | 05 | Month | 31 | Day |
Variants (PA/I38X, NA/H275YH)dynamics (RNA ratio of Wild/variant, virus titer) after infection
2021 | Year | 01 | Month | 14 | Day |
2022 | Year | 07 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048526
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |